Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03693807Phase 2Completed
Phase 2, open-label, single-arm trial in colorectal cancer (CRC) and cholangiocarcinoma (CCA), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoints: Number of Patients Requiring Stent Replacements at 1 year and Number of Participants With Any Grade Liver Toxicity at 1 year. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03693807.